반응 #70140

ord-4f0a15a511904dc2877b11674f51e089

반응 방정식

CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl
bupivacaine HCl
OCC(O)CO
glycerin
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C
bupivacaine

용매

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    workup.DISSOLUTIONdissolving
  2. 2
    workup.ADDITIONmixing
  3. 3
    workup.ADDITIONmixed
  4. 4
    workup.ADDITION20 g of granular gelatin is then added
  5. 5
    온도the composition heated carefully on a steam bath until the gelatin
  6. 6
    workup.DISSOLUTIONis dissolved
  7. 7
    workup.ADDITIONThe melted mixture is poured
  8. 8
    온도into chilled molds

실험 절차

A composition suitable for administration in vaginal suppository form 1a prepared by weighing 2 mg of finely divided polynucleotide medicinal substance into a tared container, adding 10 ml of 0.5% bupivacaine HCl in purified water, to make a total of 10 g, and dissolving or mixing depending on the solubility of the medicinal substance; 70 g of glycerin is added and mixed; 20 g of granular gelatin is then added and the composition heated carefully on a steam bath until the gelatin is dissolved. The melted mixture is poured into chilled molds to yield 20 vaginal suppositories of 6 grams each containing 100 mcg of polynucleotide medicinal substance in admixture with 2.5 mg bupivacaine.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08536145B2uspto-grants-2013_09